[8-K] Wave Life Sciences Ltd. Reports Material Event

Rhea-AI Filing Summary

Phoenix Motor Inc. (PEV) filed a Form 8-K reporting the resignation of Chief Financial Officer Michael Yung, effective 2 Aug 2025. The company states Mr. Yung left for personal reasons and had no disagreements regarding the firm’s operations or accounting practices.

CEO Denton Peng will serve as interim principal financial and accounting officer while the Board undertakes an internal and external search for a permanent replacement. No additional financial results or business updates were included.

The filing also notes that trading of Phoenix Motor’s common stock was suspended on Nasdaq on 15 Apr 2025 and shares now quote on the OTC Pink under the symbol PEVMD.

Positive

• Board has committed to a formal search for an experienced CFO, signalling intent to restore financial leadership stability.

Negative

• CFO Michael Yung’s resignation removes the company’s top financial officer with immediate effect.
• CEO assuming interim CFO role concentrates key management duties, potentially stressing internal controls.

Insights

Corporate Governance Expert

TL;DR: Sudden CFO exit heightens governance risk; interim CEO dual-hat may worry investors.

The unexpected resignation of the CFO at a micro-cap EV maker already delisted from Nasdaq compounds oversight concerns. Even though the company claims no accounting disagreements, losing a key financial steward without an immediate successor can disrupt reporting processes and lender confidence. CEO Denton Peng’s assumption of CFO duties creates high key-person concentration and potential internal control strain until a qualified finance chief is hired.

Financial Analyst

TL;DR: Leadership gap is notable but no direct financial data provided; impact modest near term.

While management turnover is negative, the filing lacks earnings or liquidity metrics, limiting quantitative assessment. Investors will monitor how quickly the board secures an experienced CFO and whether the change affects audit timelines or capital-raising plans. Given shares already trade OTC, market reaction may be muted unless follow-up disclosures reveal operational fallout.

false 0001631574 0001631574 2025-08-05 2025-08-05

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 5, 2025

WAVE LIFE SCIENCES LTD.

(Exact name of registrant as specified in its charter)

Singapore		001-37627		98-1356880
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

7 Straits View #12-00, Marina One
East Tower
Singapore		018936
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: +65 6236 3388

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading symbol		Name of each exchange on which registered
$0 Par Value Ordinary Shares		WVE		The Nasdaq Global Market

Item 7.01 Regulation FD Disclosure.

From time to time, Wave Life Sciences Ltd. (the “Company”) presents and/or distributes slides and presentations to the investment community to provide updates and summaries of its business. On August 5, 2025, the Company updated its corporate presentation, which is available on the “For Investors & Media” section of the Company’s website at http://ir.wavelifesciences.com/. This presentation is also furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Item 7.01 and exhibit 99.1 attached hereto is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

The following exhibit relating to Item 7.01 is furnished and not filed:

Exhibit No.		Description
99.1		Corporate Presentation of Wave Life Sciences Ltd. dated August 5, 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

WAVE LIFE SCIENCES LTD.
By:		/s/ Kyle Moran
		Kyle Moran
		Chief Financial Officer

Date: August 5, 2025

FAQ

Why did Phoenix Motor (PEV) CFO Michael Yung resign?

The Form 8-K states Mr. Yung resigned on 2 Aug 2025 for personal reasons with no disagreements on accounting or operations.

Who will handle Phoenix Motor’s financial duties after the resignation?

CEO Denton Peng will act as principal financial and accounting officer until a new CFO is appointed.

Did Phoenix Motor report any accounting issues related to the resignation?

The company specifically noted there were no disagreements regarding accounting policies or practices.

Where is Phoenix Motor’s stock currently traded?

After Nasdaq suspended trading on 15 Apr 2025, shares moved to the OTC Pink Limited Market under the symbol PEVMD.

What is the effective date of the CFO’s departure?

Michael Yung’s resignation became effective on 2 Aug 2025.